Natriumchlorid-Lösung Deltamedica (Sodium Chloride)

When infused, sodium chloride delivers Na⁺ and Cl⁻ ions directly into the bloodstream, raising plasma osmolarity and volume. The added sodium helps retain water within the vascular compartment, while chloride supports acid‑base balance and electrical neutrality, together re‑establishing normal fluid distribution.

The appropriate dose is determined by the prescribing clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Dosing is individualized and should follow institutional protocols and physician orders.

Sodium chloride is a physiologic electrolyte and is generally considered compatible with pregnancy and lactation when used as directed. However, clinicians should assess maternal and fetal status and use the lowest effective volume to avoid fluid overload.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Natriumchlorid-Lösung Deltamedica is an isotonic saline solution (0.9% NaCl) that provides balanced sodium and chloride without additional electrolytes or glucose. Compared with balanced solutions (e.g., Ringer's lactate), it lacks potassium, calcium, and lactate, making it suitable when those ions are contraindicated but less ideal for patients needing a more physiologic electrolyte mix.

Store the solution at controlled room temperature, typically below 25 °C. Keep the container sealed, protect it from moisture and direct sunlight, and ensure the vial or bag remains intact until use. Follow standard aseptic techniques during preparation and administration.

The product is administered intravenously. It can be given as a continuous infusion or intermittent bolus, depending on the clinical scenario and physician orders. Infusion sets and sterile technique must be used to maintain product integrity.

Serious risks include severe hypernatremia, pulmonary edema, and anaphylactoid reactions. These events are more likely in patients with cardiac or renal impairment, excessive infusion rates, or when combined with other sodium‑rich solutions. Continuous monitoring of fluid balance and electrolytes mitigates these risks.

Patients with severe congestive heart failure, uncontrolled hypertension, or renal failure who are at high risk for fluid overload should avoid routine use. Additionally, individuals with known hypersensitivity to the container or solution components should not receive the product.